chr15-56427605-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001395496.1(TEX9):c.964G>T(p.Asp322Tyr) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000216 in 1,519,076 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395496.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TEX9 | NM_001395496.1 | c.964G>T | p.Asp322Tyr | missense_variant, splice_region_variant | 11/12 | ENST00000696102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TEX9 | ENST00000696102.1 | c.964G>T | p.Asp322Tyr | missense_variant, splice_region_variant | 11/12 | NM_001395496.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000231 AC: 35AN: 151614Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000352 AC: 69AN: 195782Hom.: 0 AF XY: 0.000335 AC XY: 36AN XY: 107620
GnomAD4 exome AF: 0.000214 AC: 293AN: 1367344Hom.: 1 Cov.: 29 AF XY: 0.000209 AC XY: 142AN XY: 679424
GnomAD4 genome AF: 0.000231 AC: 35AN: 151732Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74136
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.964G>T (p.D322Y) alteration is located in exon 11 (coding exon 11) of the TEX9 gene. This alteration results from a G to T substitution at nucleotide position 964, causing the aspartic acid (D) at amino acid position 322 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at